Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q28303860)
Watch
English
Body fluid biomarkers in multiple sclerosis
scientific article
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PubMed publication ID
24331797
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24331797%20AND%20SRC:MED&resulttype=core&format=json
retrieved
3 March 2020
title
Body fluid biomarkers in multiple sclerosis
(English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
24331797
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24331797%20AND%20SRC:MED&resulttype=core&format=json
retrieved
3 March 2020
main subject
biomarker
0 references
multiple sclerosis
0 references
author
Xavier Montalban
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed publication ID
24331797
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24331797%20AND%20SRC:MED&resulttype=core&format=json
retrieved
3 March 2020
author name string
Manuel Comabella
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed publication ID
24331797
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24331797%20AND%20SRC:MED&resulttype=core&format=json
retrieved
3 March 2020
language of work or name
English
0 references
publication date
1 January 2014
1 reference
stated in
Europe PubMed Central
PubMed publication ID
24331797
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24331797%20AND%20SRC:MED&resulttype=core&format=json
retrieved
3 March 2020
published in
Lancet Neurology
1 reference
stated in
Europe PubMed Central
PubMed publication ID
24331797
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24331797%20AND%20SRC:MED&resulttype=core&format=json
retrieved
3 March 2020
volume
13
1 reference
stated in
Europe PubMed Central
PubMed publication ID
24331797
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24331797%20AND%20SRC:MED&resulttype=core&format=json
retrieved
3 March 2020
issue
1
1 reference
stated in
Europe PubMed Central
PubMed publication ID
24331797
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24331797%20AND%20SRC:MED&resulttype=core&format=json
retrieved
3 March 2020
page(s)
113-126
1 reference
stated in
Europe PubMed Central
PubMed publication ID
24331797
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24331797%20AND%20SRC:MED&resulttype=core&format=json
retrieved
3 March 2020
cites work
Biomarkers and surrogate endpoints: preferred definitions and conceptual framework
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970233-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Defining the clinical course of multiple sclerosis: Results of an international survey
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970233-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
MRI as a marker for disease heterogeneity in multiple sclerosis.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970233-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970233-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Predictors of long-term outcome in multiple sclerosis patients treated with interferon β.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970233-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Combination of CSF N-acetylaspartate and neurofilaments in multiple sclerosis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970233-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Axonal damage in relapsing multiple sclerosis is markedly reduced by natalizumab.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970233-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Clinically isolated syndromes
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970233-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Radiologically isolated syndrome--incidental magnetic resonance imaging findings suggestive of multiple sclerosis, a systematic review.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970233-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The immunopathology of multiple sclerosis: an overview
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970233-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Protein biomarker discovery and validation: the long and uncertain path to clinical utility
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970233-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Multiple sclerosis: Identification and clinical evaluation of novel CSF biomarkers
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970233-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Proteomics comparison of cerebrospinal fluid of relapsing remitting and primary progressive multiple sclerosis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970233-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identification of biomarkers for diagnosis and progression of MS by MALDI-TOF mass spectrometry.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970233-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Cleavage of cystatin C is not associated with multiple sclerosis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970233-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
miRNA profiling for biomarker discovery in multiple sclerosis: from microarray to deep sequencing
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970233-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Evaluation of soluble HLA-G as a biomarker for multiple sclerosis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970233-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Soluble Nogo-A in CSF is not a useful biomarker for multiple sclerosis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970233-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Lack of association between antimyelin antibodies and progression to multiple sclerosis.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970233-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Chitinase effects on immune cell response in neuromyelitis optica and multiple sclerosis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970233-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Abrogation of T cell quiescence characterizes patients at high risk for multiple sclerosis after the initial neurological event
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970233-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Tau protein and 14-3-3 are elevated in the cerebrospinal fluid of patients with multiple sclerosis and correlate with intrathecal synthesis of IgG.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970233-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Tau protein seems not to be a useful routine clinical marker of axonal damage in multiple sclerosis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970233-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Patients with progressive multiple sclerosis have elevated antibodies to neurofilament subunit.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970233-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Antibodies against light neurofilaments in multiple sclerosis patients
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970233-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Upregulation of K2P5.1 potassium channels in multiple sclerosis.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970233-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Genome-wide pharmacogenomic analysis of the response to interferon beta therapy in multiple sclerosis.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970233-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Genome-wide scan of 500,000 single-nucleotide polymorphisms among responders and nonresponders to interferon beta therapy in multiple sclerosis.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970233-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Serum IL-17F does not predict poor response to IM IFNβ-1a in relapsing-remitting MS.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970233-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
An altered immune response to Epstein-Barr virus in multiple sclerosis: a prospective study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970233-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Epstein-Barr virus and multiple sclerosis: evidence of association from a prospective study with long-term follow-up
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970233-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Anti-Epstein-Barr virus antibodies as serological markers of multiple sclerosis: a prospective study among United States military personnel
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970233-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Quantification of immunoglobulin free light chains in cerebrospinal fluid by nephelometry
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970233-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Elevated levels of kappa free light chains in CSF support the diagnosis of multiple sclerosis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970233-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Free light chain monomers in the diagnosis of multiple sclerosis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970233-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Intrathecal synthesis of oligoclonal IgM against myelin lipids predicts an aggressive disease course in MS.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970233-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Primary progressive versus relapsing-onset multiple sclerosis: presence and prognostic value of cerebrospinal fluid oligoclonal IgM.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970233-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Brain atrophy and lesion load are related to CSF lipid-specific IgM oligoclonal bands in clinically isolated syndromes
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970233-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Intrathecal synthesis of IgM measured after a first demyelinating event suggestive of multiple sclerosis is associated with subsequent MRI brain lesion accrual.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970233-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Cerebrospinal fluid oligoclonal IgM bands predict early conversion to clinically definite multiple sclerosis in patients with clinically isolated syndrome
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970233-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The role of NCAM in remyelination
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970233-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Elevated levels of neural recognition molecule L1 in the cerebrospinal fluid of patients with Alzheimer disease and other dementia syndromes.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970233-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Neural cell adhesion molecule--description of a CSF ELISA method and evidence of reduced levels in selected neurological disorders
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970233-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Increased urinary nitric oxide metabolites in patients with multiple sclerosis correlates with early and relapsing disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970233-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Increased intrathecal nitric oxide formation in multiple sclerosis; cerebrospinal fluid nitrite as activity marker
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970233-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Nitric oxide as an activity marker in multiple sclerosis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970233-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
CSF nitric oxide metabolites are associated with activity and progression of multiple sclerosis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970233-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
IFNbeta lowers MMP-9/TIMP-1 ratio, which predicts new enhancing lesions in patients with SPMS.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970233-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Serum MMP-2 and MMP-9 are elevated in different multiple sclerosis subtypes
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970233-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Cerebrospinal fluid and serum levels and intrathecal production of active matrix metalloproteinase-9 (MMP-9) as markers of disease activity in patients with multiple sclerosis.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970233-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Matrix metalloproteinase-9 and matrix metalloproteinase-2 as biomarkers of various courses in multiple sclerosis.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970233-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Immunoreactive myelin basic protein in the cerebrospinal fluid in neurological disorders
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970233-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A correlative triad of gadolinium-DTPA MRI, EDSS, and CSF-MBP in relapsing multiple sclerosis patients treated with high-dose intravenous methylprednisolone
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970233-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Myelin basic protein in CSF as indicator of disease activity in multiple sclerosis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970233-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Osteopontin levels and increased disease activity in relapsing-remitting multiple sclerosis patients
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970233-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Plasma osteopontin levels in multiple sclerosis.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970233-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Osteopontin concentrations are increased in cerebrospinal fluid during attacks of multiple sclerosis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970233-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Increased cerebrospinal fluid concentrations of the chemokine CXCL13 in active MS.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970233-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Cerebrospinal fluid CXCL13 in multiple sclerosis: a suggestive prognostic marker for the disease course.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970233-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Multiple sclerosis: BAFF and CXCL13 in cerebrospinal fluid
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970233-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Markers for different glial cell responses in multiple sclerosis: clinical and pathological correlations
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970233-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Neurofilament and glial fibrillary acidic protein in multiple sclerosis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970233-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Glial fibrillary acidic protein: a potential biomarker for progression in multiple sclerosis.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970233-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Brain-derived neurotrophic factor in patients with multiple sclerosis.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970233-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Neurotrophic factors and clinical recovery in relapsing-remitting multiple sclerosis.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970233-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Increased plasma levels of brain derived neurotrophic factor (BDNF) after multiple sclerosis relapse.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970233-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Potassium channel KIR4.1 as an immune target in multiple sclerosis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970233-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Acute optic neuritis: combined immunological markers and magnetic resonance imaging predict subsequent development of multiple sclerosis. The Optic Neuritis Study Group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970233-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
IgG antibodies against measles, rubella, and varicella zoster virus predict conversion to multiple sclerosis in clinically isolated syndrome
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970233-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Cerebrospinal fluid chitinase 3-like 1 levels are associated with conversion to multiple sclerosis.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970233-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Complement regulator factor H as a serum biomarker of multiple sclerosis disease state.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970233-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A type I interferon signature in monocytes is associated with poor response to interferon-beta in multiple sclerosis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970233-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Glypican 5 is an interferon-beta response gene: a replication study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970233-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
HLA-DRB1*0401 and HLA-DRB1*0408 are strongly associated with the development of antibodies against interferon-beta therapy in multiple sclerosis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970233-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Interleukin-17 production in central nervous system-infiltrating T cells and glial cells is associated with active disease in multiple sclerosis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970233-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Cerebrospinal fluid BAFF and APRIL levels in neuromyelitis optica and multiple sclerosis patients during relapse
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970233-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Tumor necrosis factor alpha (TNF-α), anti-TNF-α and demyelination revisited: an ongoing story
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970233-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Th1 versus Th17: are T cell cytokines relevant in multiple sclerosis?
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970233-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Genome-wide association study identifies new multiple sclerosis susceptibility loci on chromosomes 12 and 20.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970233-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970233-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Meta-analysis of genome scans and replication identify CD6, IRF8 and TNFRSF1A as new multiple sclerosis susceptibility loci
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970233-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970233-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Neurofilament heavy chain in CSF correlates with relapses and disability in multiple sclerosis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970233-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Acute axonal damage predicts clinical outcome in patients with multiple sclerosis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970233-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Axonal damage markers in the cerebrospinal fluid of patients with clinically isolated syndrome improve predicting conversion to definite multiple sclerosis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970233-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970233-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Clinical, environmental, and genetic determinants of multiple sclerosis in children with acute demyelination: a prospective national cohort study.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970233-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Vitamin D status predicts new brain magnetic resonance imaging activity in multiple sclerosis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970233-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Interferon-β and serum 25-hydroxyvitamin D interact to modulate relapse risk in MS.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970233-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effect of anti-CD25 antibody daclizumab in the inhibition of inflammation and stabilization of disease progression in multiple sclerosis.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970233-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Daclizumab in active relapsing multiple sclerosis (CHOICE study): a phase 2, randomised, double-blind, placebo-controlled, add-on trial with interferon beta
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970233-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970233-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Natalizumab plus interferon beta-1a for relapsing multiple sclerosis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970233-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Occurrence of antibodies against natalizumab in relapsing multiple sclerosis patients treated with natalizumab
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970233-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A Swedish national post-marketing surveillance study of natalizumab treatment in multiple sclerosis.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970233-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Kinetics and incidence of anti-natalizumab antibodies in multiple sclerosis patients on treatment for 18 months
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970233-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Characterization of anti-natalizumab antibodies in multiple sclerosis patients
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970233-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Guidelines on use of anti-IFN-beta antibody measurements in multiple sclerosis: report of an EFNS Task Force on IFN-beta antibodies in multiple sclerosis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970233-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Neutralizing antibodies to interferon beta: assessment of their clinical and radiographic impact: an evidence report: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970233-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Recommendations for clinical use of data on neutralising antibodies to interferon-beta therapy in multiple sclerosis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970233-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Recommended standard of cerebrospinal fluid analysis in the diagnosis of multiple sclerosis: a consensus statement
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970233-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Oligoclonal bands in multiple sclerosis cerebrospinal fluid: An update on methodology and clinical usefulness
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970233-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The spectrum of neuromyelitis optica
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970233-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970233-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Revised diagnostic criteria for neuromyelitis optica
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970233-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Risk of natalizumab-associated progressive multifocal leukoencephalopathy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970233-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Vaccination against infection in patients with multiple sclerosis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970233-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phenotypical and functional characterization of T helper 17 cells in multiple sclerosis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970233-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Inhibition of soluble tumour necrosis factor is therapeutic in experimental autoimmune encephalomyelitis and promotes axon preservation and remyelination
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970233-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Repeated subcutaneous injections of IL12/23 p40 neutralising antibody, ustekinumab, in patients with relapsing-remitting multiple sclerosis: a phase II, double-blind, placebo-controlled, randomised, dose-ranging study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970233-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Why did IL-12/IL-23 antibody therapy fail in multiple sclerosis?
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970233-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970233-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Aggregation of multiple sclerosis genetic risk variants in multiple and single case families
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970233-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Regulatory CD56(bright) natural killer cells mediate immunomodulatory effects of IL-2Ralpha-targeted therapy (daclizumab) in multiple sclerosis.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970233-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Intrathecal effects of daclizumab treatment of multiple sclerosis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970233-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The incidence and significance of anti-natalizumab antibodies: results from AFFIRM and SENTINEL.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970233-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Neuromyelitis optica: clinical predictors of a relapsing course and survival
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970233-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Anti-John Cunnigham virus antibody prevalence in multiple sclerosis patients: baseline results of STRATIFY-1.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970233-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Fingolimod treatment for multiple sclerosis patients What do we do with varicella?
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970233-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Immunization in the adult immunocompromised host
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970233-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Bioavailability of interferon beta 1b in MS patients with and without neutralizing antibodies
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970233-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Persistent neutralizing antibodies abolish the interferon beta bioavailability in MS patients.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970233-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Absence of MxA induction by interferon beta in patients with MS reflects complete loss of bioactivity
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970233-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Do oligoclonal bands add information to MRI in first attacks of multiple sclerosis?
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970233-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970233-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The clinical course of neuromyelitis optica (Devic's syndrome).
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970233-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Immunosuppressive therapy is more effective than interferon in neuromyelitis optica.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970233-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Interferon beta-1b exacerbates multiple sclerosis with severe optic nerve and spinal cord demyelination
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970233-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Natalizumab-associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: lessons from 28 cases
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970233-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Anti-JC virus antibodies: implications for PML risk stratification
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970233-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970233-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Primary varicella zoster infection associated with fingolimod treatment
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970233-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Measles outbreak in Barcelona. Clinical and epidemiological characteristics
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970233-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effect of feeding on bone turnover markers and its impact on biological variability of measurements.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970233-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Nocturnal plasma levels of cytokines in healthy men.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970233-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Anticoagulants affect matrix metalloproteinase 9 levels in blood samples of stroke patients and healthy controls
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970233-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Genome-wide comparison of two RNA-stabilizing reagents for transcriptional profiling of peripheral blood
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970233-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970233-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Pre-analytical influence on the low molecular weight cerebrospinal fluid proteome
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970233-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Sample handling for mass spectrometric proteomic investigations of human sera.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970233-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The effects of test temperature and storage temperature on platelet aggregation: a whole blood in vitro study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970233-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Preanalytic and analytic sources of variations in C-reactive protein measurement: implications for cardiovascular disease risk assessment
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970233-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The road from discovery to clinical diagnostics: lessons learned from the first FDA-cleared in vitro diagnostic multivariate index assay of proteomic biomarkers
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970233-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Genomics in multiple sclerosis--current state and future directions.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970233-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Consensus definitions and application guidelines for control groups in cerebrospinal fluid biomarker studies in multiple sclerosis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970233-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Pharmacogenomics in neurology: current state and future steps
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970233-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The complex genetics of multiple sclerosis: pitfalls and prospects
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970233-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Errors in clinical laboratories or errors in laboratory medicine?
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970233-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Why most published research findings are false
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970233-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Statistical strategies for avoiding false discoveries in metabolomics and related experiments
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970233-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Microarray data analysis: from disarray to consolidation and consensus
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970233-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Matrix metalloproteinase-9 and autoimmune diseases
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970233-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The role of osteopontin in inflammatory processes
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970233-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Correlation of clinical features and findings on cranial magnetic resonance imaging with urinary myelin basic protein-like material in patients with multiple sclerosis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970233-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Surrogate endpoints in clinical trials: definition and operational criteria
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970233-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Disability outcome measures in multiple sclerosis clinical trials: current status and future prospects
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970233-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Personalized medicine using DNA biomarkers: a review
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970233-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Cerebrospinal fluid and urinary biomarkers in multiple sclerosis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970233-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Silver stained isoelectrophoresis of tears and cerebrospinal fluid in multiple sclerosis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970233-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Tear analysis in clinically isolated syndrome as new multiple sclerosis criterion
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970233-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Bio-Rad's Bio-Plex® suspension array system, xMAP technology overview
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970233-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Clinical performance characteristics of a laboratory test. A practical approach in the autoimmune laboratory
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970233-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Integrating biomarkers in clinical trials
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970233-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Science, medicine, and the future: Pharmacogenetics
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970233-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Defining the response to interferon-β in relapsing-remitting multiple sclerosis patients
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970233-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identifiers
DOI
10.1016/S1474-4422(13)70233-3
2 references
stated in
Consolidated OpenCitations Corpus – April 2017
OpenCitations bibliographic resource ID
369279
stated in
Europe PubMed Central
PubMed publication ID
24331797
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24331797%20AND%20SRC:MED&resulttype=core&format=json
retrieved
3 March 2020
OpenCitations bibliographic resource ID
369279
1 reference
stated in
Consolidated OpenCitations Corpus – April 2017
OpenCitations bibliographic resource ID
369279
PubMed publication ID
24331797
2 references
stated in
Consolidated OpenCitations Corpus – April 2017
OpenCitations bibliographic resource ID
369279
stated in
Europe PubMed Central
PubMed publication ID
24331797
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24331797%20AND%20SRC:MED&resulttype=core&format=json
retrieved
3 March 2020
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit